Detailed Information
Cited 2 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Leveraging innate immunity with AFM24, a novel CD16A and epidermal growth factor receptor (EGFR) bispecific innate cell engager: Interim results for the non-small cell lung cancer (NSCLC) cohort
- Authors
- El-Khoueiry, AB[El-Khoueiry, Anthony B.]; Rivas, D[Rivas, Delcia]; Lee, SH[Lee, Se-Hoon]; Thomas, JS[Thomas, Jacob Stephen]; Kim, YJ[Kim, Yu Jung]; Cervantes, A[Cervantes, Andres]; Saavedra, O[Saavedra, Omar]; Shim, BY[Shim, Byoung Yong]; Kohlhas, L[Kohlhas, Laura]; Hintzen, G[Hintzen, Gabriele]; Emig, M[Emig, Michael]; Nava-Parada, P[Nava-Parada, Pilar]
- Issue Date
- 1-Jun-2023
- Publisher
- LIPPINCOTT WILLIAMS & WILKINS
- Citation
- JOURNAL OF CLINICAL ONCOLOGY, v.41, no.16
- Indexed
- SCIE
SCOPUS
- Journal Title
- JOURNAL OF CLINICAL ONCOLOGY
- Volume
- 41
- Number
- 16
- ISSN
- 0732-183X
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.